Author:
Sørensen Anna Irene Vedel,Spiliopoulos Lampros,Bager Peter,Nielsen Nete Munk,Hansen Jørgen Vinsløv,Koch Anders,Meder Inger Kristine,Hviid Anders,Ethelberg Steen
Abstract
AbstractIt is not well-described how the acute symptoms of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) differ by variant, vaccination, sex and age. A cross-sectional questionnaire study linked to national testing- and registry data was conducted among 148,874 SARS-CoV-2 first time reverse transcription polymerase chain reaction (RT-PCR) test-positive individuals and corresponding date-matched symptomatic test-negative controls. Major SARS-CoV-2 variants (Index/wild type, Alpha, Delta and Omicron) were defined using periods of predominance. Risk differences (RDs) were estimated for each of 21 predefined acute symptoms comparing: (1) test-positive and -negative individuals, by variant period, (2) vaccinated and unvaccinated test-positives, by variant period, (3) individuals tested positive during the Omicron and Delta periods, by vaccination status, and (4) vaccinated Omicron test-positive and -negative individuals, by age and sex. Compared to pre-Omicron, RDs between test-positive and test-negative individuals during the Omicron period were lower for most symptoms. RDs for altered sense of smell (dysosmia) and taste (dysgeusia) were highest for Delta (RD = 50.8 (49.4–52.0) and RD = 54.7 (53.4–56.0), respectively) and lowest for Omicron (RD = 12.8 (12.1–13.5) and RD = 11.8 (11.1–12.4), respectively). Across variants, vaccinated individuals reported fewer symptoms. During Omicron, females and 30–59 year-old participants reported more symptoms.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Spinato, G. et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA 323, 2089–2090 (2020).
2. Struyf, T. et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 (Review). Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD013665.pub3 (2022).
3. Bager, P. et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: An observational cohort study. Lancet Infect. Dis. 3099, 1–10 (2022).
4. Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study. Lancet 399, 1618–1624 (2022).
5. Wang, R. C. et al. Association between SARS-CoV-2 variants and frequency of acute symptoms: Analysis of a multi-institutional prospective cohort study—December 20, 2020–June 20, 2022. Open Forum Infect. Dis. (2023)